ReviewF1000prime reports2013
New and alternative approaches to tackling antibiotic resistance.
Review in F1000prime reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Genes and physiological strategies in bacterial antibiotic resistance.Frontiers in microbiology · 2026Review
- Treatment of MRSA Infection: Where are We?Current medicinal chemistry · 2024Review
- The Effect of Mesenchymal Stem Cells on the Wound Infection.Current stem cell research & therapy · 2024Review
- Comparative Analysis of Stable Gold Nanoparticles Synthesized Using Sonochemical and Reduction Methods for Antibacterial Activity.Molecules (Basel, Switzerland) · 2023Article
- Anti-Frontiers in microbiology · 2023Review
- Antimicrobial Resistance and Antibiogram of ThermotolerantArchives of Razi Institute · 2022Article
- In Vitro Potentiation of Antimicrobial Photodynamic Inactivation by Addition of Potassium Iodide.Methods in molecular biology (Clifton, N.J.) · 2022Article
- Synthesis, Characterization and In Vitro Antibacterial Evaluation ofNanomaterials (Basel, Switzerland) · 2021Article
- Antibacterial effects assessment on some livestock pathogens, thermal stability and proposing a probable reason for different levels of activity of thanatin.Scientific reports · 2021Article
- Novel 3,4-Dihydroisocoumarins Inhibit Human P-gp and BCRP in Multidrug Resistant Tumors and Demonstrate Substrate Inhibition of Yeast Pdr5.Frontiers in pharmacology · 2019Article
- Antibiotics, Resistome and Resistance Mechanisms: A Bacterial Perspective.Frontiers in microbiology · 2018Review
- Adaptation ofFrontiers in microbiology · 2018Article
- Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds.Stem cell research & therapy · 2017Article
- Beyond conventional antibiotics - New directions for combination products to combat biofilm.Advanced drug delivery reviews · 2017Review
- Review
- Microbial profiles at baseline and not the use of antibiotics determine the clinical outcome of the treatment of chronic periodontitis.Scientific reports · 2016Article
- Antimicrobial Drugs in Fighting against Antimicrobial Resistance.Frontiers in microbiology · 2016Review
- Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity.Frontiers in microbiology · 2016Article
- Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.Nanomedicine (London, England) · 2015Article
- Anti-infective potential of a quorum modulatory polyherbal extract (panchvalkal) against certain pathogenic bacteria.Journal of Ayurveda and integrative medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multidrug-resistant bacteria are becoming more common and due to their multiplicity of mechanisms, they are frequently resistant to many if not all of the current antibiotics. This daunting spectre has been the target of many research efforts into conventional antibiotics and alternative approaches. This review focuses on the more recent advances in these fields with an overview on peptidomimetics, nanoparticles and their derivatives, FimH inhibitors, quorum sensing inhibition molecules, neoglycosides and phage therapies. These various approaches are at different stages of development, some are closer to the clinic than others, but recent regulatory guidance and re-awakened interest from the pharmaceutical companies gives us some optimism for the future.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.